Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma.

ABSTRACT:

Background

We aimed to identify the prognostic factors for late intrahepatic recurrence (IHR), defined as recurrence more than two years after curative treatment of newly diagnosed hepatocellular carcinoma (HCC).

Methods

This retrospective cohort study included patients with newly diagnosed, previously untreated, very early, or early HCC treated with initial curative treatment and followed up without recurrence for more than two years, excluding early IHR defined as recurrence within two years in single center. Late IHR-free survival (IHRFS) was defined as the time interval from initial curative treatment to the first IHR or death without IHR, whichever occurred first.

Results

Among all the enrolled 2,304 patients, 1,427 (61.9%) underwent curative intent hepatectomy a

SUBMITTER: Goh MJ 

PROVIDER: S-EPMC11444816 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature